When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADAP - European committee backs Adaptimmune Therapeutics' ADP-A2M4 for Orphan Drug
Adaptimmune Therapeutics plc
The EMA's Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion for Orphan Drug Designation (ODD) for Adaptimmune Therapeutics' (NASDAQ:ADAP) ADP-A2M4 for the treatment of soft tissue sarcomas.
More news on: Adaptimmune Therapeutics plc, Healthcare stocks news, Stocks on the move,